[1]
Ali Hammed, S. and Fadhil Alwan, A. 2025. Metastatic EGFR-Mutant Lung Adenocarcinoma Patients: A Safety and Efficacy Analysis of First- and Third-Generation EGFR-TKIs. Middle Eastern Cancer and Oncology Journal. 1, 4 (Dec. 2025), 20–25. DOI:https://doi.org/10.61706/MECOJ160189.